文献速递肿瘤 PET/CT核素与放射性配体治疗

数字与模拟PET在复发性前列腺癌[68Ga]Ga-PSMA-11 PET/CT中的配对比较

Digital versus analogue PET in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer: a matched-pair comparison.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2019-12-02

该回顾性配对研究纳入88例在数字PET/CT(dPET/CT)行[68Ga]Ga-PSMA-11检查的复发性前列腺癌患者,并与88例临床参数匹配的模拟PET/CT(aPET/CT)患者比较。dPET/CT检出更多前列腺癌病灶(326 vs 142)及良性PSMA阳性病灶(144 vs 65),且病理阳性扫描更多(74/88 vs 64/88,p<0.05)。在最低PSA值组(PSA<2.0 ng/ml),dPET/CT的PSMA阳性率显著更高(p<0.05)。

要点

  • dPET/CT较aPET/CT检出更多前列腺癌病灶(326 vs 142)。
  • dPET/CT病理阳性扫描比例更高(74/88 vs 64/88,p<0.05)。
  • PSA<2.0 ng/ml时dPET/CT的PSMA阳性率显著更高(p<0.05)。

核心结论

  • dPET/CT较aPET/CT检出更多前列腺癌病灶,且在最低PSA值组病理阳性率显著更高。
  • dPET/CT也检出更多良性PSMA阳性病灶,差异可由测得的扫描仪成像特性解释。

研究设计与样本

  • 回顾性配对研究,第一队列为88例在数字PET/CT行[68Ga]Ga-PSMA-11检查的复发性前列腺癌患者。
  • 第二队列为88例经临床参数匹配后行模拟[68Ga]Ga-PSMA-11 PET/CT的个体。
  • 由两名核医学医师共识阅片记录前列腺癌病灶及良性PSMA阳性病灶的数量与类型,并辅以[68Ga]Ga体模测量。

主要发现

  • dPET/CT检出前列腺癌病灶326个,aPET/CT检出142个。
  • dPET/CT检出良性PSMA阳性病灶144个,aPET/CT检出65个。
  • dPET/CT病理阳性扫描为74/88,aPET/CT为64/88(p<0.05)。
  • 在PSA<2.0 ng/ml的最低PSA值组,dPET/CT的PSMA阳性率显著更高(p<0.05)。

临床怎么用

  • 在复发性前列腺癌生化复发评估中,可优先考虑数字PET/CT以提升病灶检出,尤其低PSA(<2.0 ng/ml)患者。
  • 阅片时需注意数字PET/CT良性PSMA阳性病灶检出增多,避免误判。

局限性

  • 本研究为回顾性设计。
  • 样本来自单中心连续队列及匹配对照,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Digital PET/CT scanners represent a significant step forward in molecular imaging. We report here the clinical impact of digital PET in PSMA-PET/CT. METHODS: In this retrospective study, 88 consecutive patients who underwent [68Ga]Ga-PSMA-11 PET/CT on a digital PET/CT (dPET/CT) scanner for recurrent prostate cancer (PC) were included in a first cohort. In a second step, 88 individuals who underwent an analogue [68Ga]Ga-PSMA-11 PET/CT (aPET/CT) were selected after they were matched to the first cohort for clinical parameters. Following consensus read by two nuclear medicine physicians, the number and type of PC lesions as well as benign, PSMA-positive lesions were recorded. The results were complemented by extensive [68Ga]Ga phantom measurements to determine imaging characteristics of both scanners. RESULTS: dPET/CT revealed a greater number of PC lesions compared to aPET/CT (326 versus 142) as well as a proportional increase in benign causes of tracer-uptake (144 versus 65). A greater number of scans were noted as pathological for PC on dPET/CT (74/88) compared to aPET/CT (64/88, p < 0.05). The PSMA positivity rate for PC was significantly higher in dPET/CT for the lowest PSA values (PSA < 2.0 ng/ml, p < 0.05). CONCLUSION: dPET/CT detected more PC lesions compared to aPET/CT. A significantly higher rate of pathological PET/CTs was noted in the group with the lowest PSA values. A higher number of benign PSMA-positive lesions were also noted in dPET/CT. The differences could be plausibly explained by the measured imaging characteristics of the scanners.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Alberts I, Prenosil G, Sachpekidis C, et al. Digital versus analogue PET in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer: a matched-pair comparison. Eur J Nucl Med Mol Imaging. 2019. PMID: 31792572. doi:10.1007/s00259-019-04630-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。